CSI Market
Sign In | Register

Thermo Fisher Scientific Inc (TMO) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access TMO Annual Cash Flow →
A period-by-period view of cash flow from Thermo Fisher Scientific Inc to Jun 28 2025 helps clarify how Jun 27 2026's cash position has changed over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 27 2026)
6 Months 		(Mar 28 2026) (Dec 31 2025) (Sep 27 2025) (Jun 28 2025)
Operating Activities
Income3,397.00
Depreciation & amortization638.00
Amortization of Other Assets915.00
Extraordinary item0.00
Restructuring reserve132.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.00
Minority interest0.00
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal0.00
Share-based Compensation165.00
Income from affiliates-23.00
Gains (Losses) on Extinguishment of Debt0.00
Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax-
Discontinued Operation Gain Loss On Disposal Net Of Tax-
Increase Decrease In Operating Capital Excluding Deferred Taxes-1,112.00
Income taxes0.00
Losses/ -gains on investments net23.00
Increase (Decrease) in Accounts Receivable0.00
Increase (Decrease) in Accounts Payable0.00
Accrued expenses0.00
Post-retirement benefits expense0.00
Increase (Decrease) in Deferred Income Taxes0.00
Other Working Capital1,537.00
Other Noncash Income (Expense)-205.00
Other net10.00
Payments for (Proceeds from) Other Operating Activities-3,272.00
Discontinued operations0.00
Net Cash flow from Operating Activities3,317.00
Investing Activities
Capital Expenditures-826.00
Sale of Capital Items13.00
Short-term investments liq.0.00
Short-term investments acq.0.00
Derivative instruments0.00
Proceeds From Payments For Cross Currency Interest Rate Swap Interest Settlements96.00
Increase (Decrease) in Restricted Cash0.00
Noncontrolling interest0.00
Proceeds from Investments0.00
Payments for (Proceeds from) Other Investments218.00
Purchases of non-current assets0.00
Payments to Acquire Businesses, Net of Cash Acquired-8,872.00
Investment in affiliate0.00
Proceeds from Divestiture of Businesses, Net of Cash Divested0.00
Proceeds from sale of assets0.00
Notes receivable0.00
Payments for (Proceeds from) Other Investing Activities1.00
Other Net669.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-8,797.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings5,238.00
Long-term debt - repayments-1,412.00
Noncontrolling interest0.00
Issuances / -repurchases of Comm. Stock-4,000.00
Exercise of stock options0.00
Issuances / -repurchases of Pref. Stock0.00
Discontinued Operations0.00
Other financing activities net33.00
Other net0.00
Dividends paid to minority interests0.00
Dividends paid-337.00
Net Cash Flow from Financing Activities-478.00
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow2,504.00
Total Cash Flow-5,782.00
4 historic quarters locked

Sign in to unlock the full Thermo Fisher Scientific Inc cash flow history.

Sign In Create Free Account

About Thermo Fisher Scientific Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20260627)
  • Filed with the SEC: July 31, 2026
  • Source: tmo-20260627.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0000097745-26-000144

Figures are derived from filed reports and may be restated. Historical data is subject to revision.